Redline Capital Competitors

DeBere Capital Partners is a private investment firm focused on high-impact opportunities across life sciences, deep tech, consumer health, and SaaS. We invest directly in the funds and companies we identify, and we represent a portfolio of innovative growth companies, VC and Private Equity funds through strategic partnerships in a placement capacity. We also invest through aligned syndicates, combining corporate finance expertise with strategic capital. Our core interests include breakthrough therapeutics, gene therapy, neurotech, and longevity biotech. In deep tech, we target innovations in Space Technology, AI, neurotechnology, robotics, and next-gen computing. In consumer health, we back brands in fitness, skincare, wellness, and performance. In SaaS, we focus on digital health, telemedicine, and personalized care.

AltAssets is an independent private equity news, information and research source. We serve over 800 limited partners and 15,000 private equity professionals with comprehensive, up-to-date information, analysis and opinions.

Private Equity News is a monthly magazine about the private equity industry. It is based in Europe and is part of the Dow Jones media group. It has been running since 2003 and is a sister title to Financial News.